Original Article

Implementation and Assessment of a Pharmacy-Led Inpatient Transitions of Care Program

Authors: David Evans, PharmD, Justin Usery, PharmD, BCPS


Objective: To evaluate pharmacist involvement in the inpatient transition of care (TOC) process for patients hospitalized with type 1 diabetes mellitus, type 2 diabetes mellitus, or chronic obstructive pulmonary disease.

Methods: A pharmacist screened patients admitted with one or more of the qualifying conditions within 48 hours of admission to perform medication reconciliation. During medication reconciliation, the pharmacist removed any duplicate or nonindicated medications and added any omitted medications. The pharmacist also reviewed the discharge summary to ensure medication optimization upon discharge.

Results: Pharmacist involvement in the admission and discharge reconciliation processes of the 50 identified patients was 100% and 44%, respectively. A medication-related problem was identified in 96% (n = 48) of patients, representing 338 pharmacist-mediated interventions with an average of 6.8 ± 4.0 (range 0–16) interventions per patient. Of those 338 interventions, 298 drug discrepancies were identified and corrected, with an average of 6.0 ± 3.7 (range 0–15) discrepancies per patient. Average time spent was 66 ± 22 (range 30–130) minutes with each patient. Of the 50 patients enrolled, 12 were readmitted within 30 days.

Conclusions: This pilot study demonstrated an improved medication reconciliation process with pharmacist involvement, expanding the body of evidence that pharmacists can enhance TOC management in an inpatient setting. These results highlight the utility of a pharmacist in the implementation and refinement of TOC services and provides impetus for a team-based approach when patients experience a TOC.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. The Joint Commission. Transitions of care: the need for a more effective approach to continuing patient care. https://www.jointcommission.org/-/media/deprecated-unorganized/imported-assets/tjc/system-folders/topics-library/hot_topics_transitions_of_carepdf.pdf?db=web&amphash=CEFB254D5EC36E4FFE30ABB20A5550E0. Published June 2012. Accessed March 16, 2020.
2. Ploenzke C, Kemp T, Naidl T, et al. Design and implementation of a targeted approach for pharmacist-mediated medication management at care transitions. J Am Pharm Assoc (2003) 2016;56:303-309.
3. Forster AJ, Murff HJ, Peterson JF, et al. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003;138:161-67.
4. Whalley AS, Salvo MC, Levine SF, Chamberlin KW, Beaudoin D. Evaluation of pharmacist involvement in outpatient transitions of care. J Gen Intern Med 2018;33:1227-1228.
5. Centers for Medicare & Medicaid Services. Community-based care transitions program. innovation.cms.gov/initiatives/CCTP. Accessed September 20, 2018.
6. Walker PC, Tucker Jones JN, Mason NA. An advanced pharmacy practice experience in transitional care. Am J Pharm Educ 2010;74:20.
7. Forster AJ, Murff HJ, Peterson JF, et al. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005;20:317-323.
8. Halasyamani L, Kripalani S, Coleman E, et al. Transition of care for hospitalized elderly patients-development of a discharge checklist for hospitalists. J Hosp Med 2016;1:354-360.
9. Visram K, Carr LS, Petrongolo JD. Implementation and assessment of a required transitions-of-care residency rotation. Am J Health Syst Pharm 2016;73:e255-e260.
10. Carter JA, Carr LS, Collins J, et al. STAAR: improving the reliability of care coordination and reducing hospital readmissions in an academic medical centre. BMJ Innov 2015;1:75-80.
11. Salas CM, Miyares MA. Implementing a pharmacy resident run transition of care service for heart failure patients: effect on readmission rates. Am J Health Syst Pharm 2015;72(11 suppl 1):S43-S47.
12. Otsuka S, Smith JN, Pontiggia L, et al. Impact of an interprofessional transition of care service on 30-day hospital reutilizations. J Interprof Care 2018;August 29:1-6.
13. Mueller SK, Sponsler KC, Kripalani S, et al. Hospital-based medication reconciliation practices: a systematic review. Arch Intern Med 2012;172:1057-1069.
14. Chen CC, Hsiao FY, Shen LJ, et al. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit. Medicine (Baltimore) 2017;96:e7883.
15. Cornish PL, Knowles SR, Marchesano R, et al. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med 2015;165:424-429.
16. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm 2010;58:1126-1132.
17. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997;277:301-306.
18. Fingar K, Washington R. Trends in Hospital Readmissions for Four High-Volume Conditions, 2009-2013. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb196-Readmissions-Trends-High-Volume-Conditions.jsp. Published November 2015. Accessed June 6, 2019.
19. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29-34.